Recurrences Completed Phase 4 Trials for Varenicline (DB01273)

Back to Recurrences

Also known as: Recurrence

IndicationStatusPhase
DBCOND0050633 (Recurrences)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00944554Relapse Prevention With VareniclineDiagnostic